Sarcopenia, Active Aging and Oral Microbiota. Effects of HIIT in Older Adults
Sarcopenia
About this trial
This is an interventional treatment trial for Sarcopenia
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 65 years
- SARC-F ≥4 or handgrip strength <16 kg for women and < 27 kg for men.
- Not being afflicted by any condition preventing physical activity.
- Not being engaged in regular physical activity >20 minutes and >3 days/week.
- Being able to communicate without difficulty.
- Being able to read and understand the informed consent form as well as the goals of the study.
Exclusion Criteria:
- Acute or terminal illness.
- Unstable cardiovascular conditions.
- Conditions or medical treatments affecting the normal production of saliva (i.e. autoimmune disorders such as Sjögren's syndrome or medications like anxiolytics or antidepressants).
- Being or having been medicated with antibiotics up to one month prior to the taking of samples.
- Alcohol abuse or regular drug abuse.
- Severe visual or auditory impairment.
- Being involved in a different research group with the potential to interfere in our results.
Sites / Locations
- Andina Area University Foundation
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
HIIT Group
MICT Group
Control Group
This group receives a training in which intervals of intense work and periods of active rest are combined using a cycle ergometer with an intensity of 85-95% of the maximum heart rate [MHR], followed by intervals of active rest of 3 minutes duration. at 50-70% MCF.
The participants will perform a training on the cycle ergometer with an intensity close to 70% FCM maintained for 40 minutes and will be controlled individually.
The participants will receive advice on the general positive effects of the regular practice of physical activity, and will be given the guide of recommendations for the promotion of physical activity.